Buy Heroin Switzerland

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Buy Heroin Switzerland

Diacetylmorphine pharmaceutical heroin substitution treatment is intended for individuals with a severe heroin addiction. It is administered in specialist centres. It was first tested in Switzerland in as part of a cohort study. In the light of the positive results obtained, it was adopted as a therapeutic measure and included in the Narcotics Act in its revised version of In , some addicted persons received this treatment in 22 specialist outpatient centres and one penal institution. The FOPH is responsible for issuing licences for this treatment, for its monitoring and controlling, and for providing information pertaining to it. Further information on the various licences may be found on this page. The goals of diacetylmorphine-assisted treatment are similar to those of other substitution-based treatments:. Crime levels have been clearly reduced. Request to reduce the time limit for the dispensing of diacetylmorphine PDF, kB, Request for the exceptional dispensing of up to one month's supply of doses of diacetylmorphine PDF, kB, Notification of delegation within the framework of prescribed diacetylmorphine-assisted treatment PDF, kB, Article 3e, paragraph 3 of the Narcotics Act NarcA, Last modification Top of page. Print contact. Homepage Main navigation Content area Sitemap Search. Subnavigation Back Back Addiction counseling and therapy Substitution-assisted treatments in case of opioid dependence Diacetylmorphine-assisted heroin-assisted treatment selected. Contact information. Diacetylmorphine-assisted heroin-assisted treatment. Goals The goals of diacetylmorphine-assisted treatment are similar to those of other substitution-based treatments: to build a long-term therapeutic alliance to improve the physical and mental health of those affected and promote their social integration to facilitate low-risk use and create the conditions for permanent abstinence to distance those affected from the illegal drug scene and prevent crime associated with the supply of drugs. Diacetylmorphine-assisted treatment has been scientifically monitored and evaluated since The criteria for admission to diacetylmorphine-assisted treatment are as follows: minimum age 18 years severe heroin dependency for at least two years at least two unsuccessful treatment attempts unsatisfactory results or treatment discontinued physical, mental or social consequences of drug use. Heroin-assisted treatment in Switzerland: results of the surveys Results of , and please consult the German or French page. Legislation Diacetylmorphine-assisted treatment is strictly regulated. The legal basis is as follows:. Further information Licences for diacetylmorphine-assisted treatment Diacetylmorphine-assisted treatment is governed specifically by the Narcotics Act NarcA; RS

The Swiss heroin trials: testing alternative approaches

Buy Heroin Switzerland

Official websites use. Share sensitive information only on official, secure websites. Over half a million heroin misusers receive oral methadone maintenance treatment world-wide 1 but the maintenance prescription of injectable opioid drugs, like heroin, remains controversial. In Switzerland began a large scale evaluation of heroin and other injectable opiate prescribing that eventually involved misusers. This was done while maintaining good drug control, good order, client safety, and staff morale. The self reported use of non-prescribed heroin fell signifianctly, but other drug use was minimally affected. There were limited reports of problems in the local neighbourhood, despite the high frequency of daily attendance. Heroin diversion was not a major problem, although some trial participants were expelled for attempting to remove heroin from the clinic or to smuggle cocaine into the clinic. The Swiss trials have encouraged proposals for similar trials in other countries, including Australia, 5 and, more recently, Denmark, Luxemburg, and the Netherlands. Any country that contemplates a trial of heroin prescription will need to address several problems that arose in the Swiss trials. Secondly, in the Swiss trials heroin was prescribed as part of a comprehensive social and psychological intervention. In the absence of any comparison treatment it was impossible to disentangle the pharmacological effects of heroin from the effects of providing treatment in well resourced clinics with highly motivated staff. An assessment of this issue requires an appropriate comparison treatment. Thirdly, the unique social and political context of the Swiss trials makes it uncertain how to generalise their findings to other countries. Switzerland is a wealthy society that has a comprehensive healthcare system that includes a well developed drug treatment system whose staff have substantial experience with opioid substitution treatment. Given this limited role, the controversy surrounding heroin prescription in Switzerland and elsewhere has been out of all proportion to its likely role as a treatment option. A recent debate about heroin prescription in Australia, for example, dominated public discussion of drug policy for nearly a month before the government decided against proceeding with the trial. The debate also had other untoward effects: supporters of the trial argued that something radical was needed, thereby encouraging the view that Australia was in the midst of a national heroin crisis. Their opponents agreed but countered that this was evidence that the national policy of harm minimisation, which sanctions methadone maintenance and needle and syringe exchange, had failed. These issues have not been resolved by the Swiss trial. There are clearly still questions that remain unanswered. The most important is what is the comparative usefulness and cost effectiveness of injectable heroin and oral methadone maintenance? A convincing answer to this question would substantially improve our understanding of the role of this controversial treatment. As a library, NLM provides access to scientific literature. Find articles by Michael Farrell. Find articles by Wayne Hall. Michael Farrell : Senior lecturer. Wayne Hall : Executive director. Similar articles. Add to Collections. Create a new collection. Add to an existing collection. Choose a collection Unable to load your collection due to an error Please try again. Add Cancel.

Buy Heroin Switzerland